Navigation Links
FDA Advisers Consider Approval of Genetically Modified Salmon
Date:9/21/2010

irector of Food & Water Watch in Washington, D.C.

"We don't know if it's safe for humans to eat and the only research that has been done was done by the company," according to Hauter. "The FDA is an under-resourced agency that has had so much trouble with the regulatory system for foods -- we've had tainted eggs, poisonous peanuts and other contaminations -- and is now taking on something in a very non-transparent way."

Recently, Food & Water Watch was joined by 30 other animal welfare, consumer, environmental and fisheries groups, including the Sierra Club, which issued a statement citing concerns that the fish could escape and pose an environmental threat. Previously, another group of consumer advocates and others warned that "transgenic fish" could introduce new or unknown allergens into the food supply.

AquaBounty creates its salmon by taking a growth gene from the Chinook salmon and a gene "promoter" from the ocean pout, another type of fish, said John Buchanan, AquaBounty's director of research and development. The pout gene promoter simply turns on the Chinook salmon growth gene, and is not actually "expressed" [active] in the modified fish. The resulting salmon grow to market weight about twice as fast as ordinary Atlantic salmon, though they don't get larger overall.

While it typically takes about three years for salmon to grow to market weight, AquaBounty's salmon get there in about 18 months, Buchanan said.

To safeguard the environment, Buchanan said the eggs will be treated so that all fish that grow from them will be sterile females. That means they will not be able to reproduce, nor will they come into contact with males to reproduce with, said Buchanan, whose firm would sell the treated eggs.

While farm-raised salmon are typically grown in ocean-based tanks, the genetically modified fish would be grown in land-based tanks, also minimizing the chances of escape, he said.

"We have done a tremendous amou
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. FDA Advisers Urge Stricter Regulation of Tanning Beds
2. FDA to Broaden Disclosure on Advisers Conflicts of Interest
3. FDA Advisers Say Avastin Shouldnt Be Used for Breast Cancer
4. FDA Advisers Divided on Whether to Ban Diet Drug Meridia
5. FDA Advisers Weigh Approval of Genetically Modified Salmon
6. Connecticut Board Considers Warning About Risk Of Stroke Following Chiropractic Neck Manipulation
7. Castrate-Metastatic Prostate Cancer: Therapeutic Considerations for Advanced Disease
8. Some Parents Consider Hastening a Sick Childs Death
9. MedCath Corporation Announces Decision to Consider Strategic Options
10. New clinical prediction index to help patients considering kidney transplant
11. BMI of Texas Offers Free Educational Seminars in San Antonio for People Considering Weight Loss Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Advisers Consider Approval of Genetically Modified Salmon
(Date:3/6/2015)... Ticket Down is a reputable source for authentic ... Moda Center. After being away from the touring business ... signs of letting up on his “Garth Brooks World Tour.” ... Trisha Yearwood, to venues around the United States. The duo ... tour to the Moda Center in Portland, OR. The husband ...
(Date:3/6/2015)... As the Muscular Dystrophy Association continues to enhance its ... two new Scientific Program Officers, Amanda Haidet-Phillips, Ph.D and ... Pavlath, Ph.D, who joined MDA late last year as ... will lead MDA as it accelerates new front-line discovery ... of neuromuscular and motor neuron diseases. , ...
(Date:3/6/2015)... CA (PRWEB) March 06, 2015 US ... of three Maryland camps – two non-contact specialty camps ... be run by Perfect Performance Training, located at Bowie ... focus on developing position specific skills, speed and strength ... hosted at Salisbury University with Marvin Graves, former quarterback ...
(Date:3/6/2015)... 2015 Johnson & Johnson and Ethicon ... March 5, 2015 in Superior Court in the State ... a jury of 12 awarded Mrs. Perry $700,000 in ... with an Ethicon TVT Abbrevo plastic sling for stress ... women also awarded $5 million in punitive damages. , ...
(Date:3/6/2015)... March 06, 2015 Jvion, the ... release of a Clostridium Difficile (C Diff) predictive ... C Diff use case is the latest in ... hospital acquired infections, chronic conditions, and individual illnesses. ... C Diff solution flags at risk individuals to ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
... UK, has provided new guidelines //for dealing with Post ... psychological therapy be given to victims of PTSD. ... tough. NICE had emphasized that apart from providing food, ... important to give them psychological care to help them ...
... created a new breed of mice that can reduce free ... ,The reactive oxygen of the free radicals are known ... health and even death. The new research may be the ... of ageing. ,The new mice created by the ...
... will help in medical practitioners to diagnose lupus disease in ... a condition that happens when the body’s tissues are affected ... may produce abnormal antibodies in their blood that may attack ... and virus. This may lead to disease of the lungs, ...
... depression may be two separate conditions that frequently co-exist. ... say that it is essential to treat depression and ... ,The researchers had studied 33 women and 20 men ... extensive tenderness to touch along with intense pain and ...
... the smoking habit of 6654 people for a period of ... do causes weight gain, but the overall health effect is ... measured for effect of giving up on smoking, gaining weight ... was 20 to 44yrs, and was measured once again for ...
... Medicine had been successful in developing an early test ... to finding of neutrophil gelatinase-associated lipocalin (NGAL) as an ... patient had a cardiopulmonary bypass surgery. ,Of the ... children had developed acute renal injury. The amount of ...
Cached Medicine News:
(Date:3/6/2015)... 6, 2015  Law office of Brodsky & ... claims against the Board of Directors of Pharmacylics, ... breaches of fiduciary duty and other violations of ... the Company to AbbVie, Inc. ("AbbVie") ... http://brodsky-smith.com/900-pcyc-pharmacyclics-inc.html , or call: 877-534-2590. There is ...
(Date:3/6/2015)... LAKE FOREST, Ill. , March 6, 2015   ... and the U.S. Food and Drug Administration (FDA) on today,s ... United States . This is a watershed moment for ... medicines. As a leading global provider of biosimilars, Hospira has ... and we are a proud participant in these early stages ...
(Date:3/6/2015)... 6, 2015  Abaxis, Inc. (NasdaqGS: ABAX ... consumables for the medical, research, and veterinary markets worldwide ... research markets in the United States ... of the U.S. Department of Agriculture (USDA) has cleared ... of   A. phagocytophelium and A. platys ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Pharmacyclics, Inc. - PCYC 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 2Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 3
... SALT LAKE CITY, Feb. 28, 2011 Concentra, a ... is transforming the future of occupational and urgent care ... and engaging experiences for clients and patients. Recent customer ... the ranks of top U.S. consumer companies as a ...
... 2011 caprotec bioanalytics GmbH announced today ... of three core patents protecting its proprietary and revolutionary ... CCMS offers a novel and direct way to investigate ... functional reduction of proteome complexity. The core of the ...
Cached Medicine Technology:Concentra is Writing a New Prescription on Health Care With Outstanding Service 2Concentra is Writing a New Prescription on Health Care With Outstanding Service 3Concentra is Writing a New Prescription on Health Care With Outstanding Service 4Concentra is Writing a New Prescription on Health Care With Outstanding Service 5caprotec bioanalytics Announces Issuance In Europe of All Core Patents of Its CCMS Technology 2
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Steroid-eluting, screw-in pacing lead...
Medicine Products: